LON:THRL Target Healthcare REIT (THRL) Share Price, News & Analysis GBX 108.20 -0.80 (-0.73%) As of 12:12 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesBuy This Stock About Target Healthcare REIT Stock (LON:THRL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Target Healthcare REIT alerts:Sign Up Key Stats Today's Range 107.80▼ 110.4050-Day Range 98.50▼ 10952-Week Range 92▼ 110.40Volume6.64 million shsAverage Volume5.02 million shsMarket Capitalization£671.10 millionP/E Ratio8.61Dividend Yield5.59%Price TargetGBX 101Consensus RatingHold Company Overview Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes. Read More Target Healthcare REIT Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks27th Percentile Overall ScoreTHRL MarketRank™: Target Healthcare REIT scored higher than 27% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingHold Consensus RatingTarget Healthcare REIT has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.Downside RiskTarget Healthcare REIT has a consensus price target of GBX 101, representing about 7.3% downside from its current price of GBX 109.Amount of Analyst CoverageTarget Healthcare REIT has only been the subject of 1 research reports in the past 90 days.Read more about Target Healthcare REIT's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Target Healthcare REIT is 8.67, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.02.Price to Earnings Ratio vs. SectorThe P/E ratio of Target Healthcare REIT is 8.67, which means that it is trading at a less expensive P/E ratio than the Real Estate sector average P/E ratio of about 29.46.Price to Earnings Growth RatioTarget Healthcare REIT has a PEG Ratio of 1.48. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioTarget Healthcare REIT has a P/B Ratio of 0.98. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for THRL. Dividend2.5 / 5Dividend StrengthModerate Dividend LeadershipTarget Healthcare REIT is a leading dividend payer. It pays a dividend yield of 5.59%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthTarget Healthcare REIT does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Target Healthcare REIT is 47.10%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Target Healthcare REIT's dividend. News and Social Media0.6 / 5News SentimentN/A MarketBeat Follows2 people have added Target Healthcare REIT to their MarketBeat watchlist in the last 30 days. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Target Healthcare REIT insiders have not sold or bought any company stock.Percentage Held by Insiders0.03% of the stock of Target Healthcare REIT is held by insiders.Percentage Held by Institutions48.84% of the stock of Target Healthcare REIT is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Target Healthcare REIT's insider trading history. Receive THRL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Target Healthcare REIT and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. THRL Stock News HeadlinesTarget Healthcare REIT (LON:THRL) Stock Passes Above 50-Day Moving Average - Here's What HappenedMay 21, 2026 | americanbankingnews.comTarget Healthcare half-year profit jumps on disposal premiumsMarch 18, 2026 | lse.co.ukBNZI Breakout Watch: AI Growth Meets Turnaround Setup!Banzai International (NASDAQ: BNZI) reported full-year 2025 revenue of $12.2 million, up 169% year-over-year, with Q4 growth of 116% and gross margins expanding to 81.9% - hallmarks of a scalable SaaS model gaining traction. With over 150,000 customers, a planned acquisition of ConnectAndSell expected to add roughly $15 million in annual revenue, and a fresh Zacks Rank No. 2 Buy upgrade, institutional confidence is building. A hammer candlestick pattern also suggests potential selling exhaustion and a possible bottom formation.May 28 at 1:00 AM | Huge Alerts (Ad)Target Healthcare REIT to Host Online Interim Results Presentation for InvestorsMarch 16, 2026 | tipranks.comTarget Healthcare reports contracted rent increase in second quarterFebruary 5, 2026 | lse.co.ukAmerican Healthcare REIT price target raised to $53 from $46 at TruistNovember 27, 2025 | msn.comTarget Healthcare REIT reports 2.5% rise in NTANovember 4, 2025 | investing.comTarget Healthcare REIT Boosts Portfolio with Strategic Property DisposalNovember 4, 2025 | msn.comSee More Headlines THRL Stock Analysis - Frequently Asked Questions How have THRL shares performed this year? Target Healthcare REIT's stock was trading at GBX 97.60 at the beginning of the year. Since then, THRL shares have increased by 11.7% and is now trading at GBX 109. How were Target Healthcare REIT's earnings last quarter? Target Healthcare REIT (LON:THRL) announced its earnings results on Wednesday, March, 18th. The company reported $3.38 earnings per share (EPS) for the quarter. Target Healthcare REIT had a trailing twelve-month return on equity of 10.73% and a net margin of 104.45%. Read the conference call transcript. How do I buy shares of Target Healthcare REIT? Shares of THRL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Target Healthcare REIT own? Based on aggregate information from My MarketBeat watchlists, some other companies that Target Healthcare REIT investors own include Realty Income (O), AT&T (T), Cambian Group (CMBN), Meta Platforms (META), Pfizer (PFE), Primary Health Properties (PHP) and Aviva (AV). Company Calendar Last Earnings3/18/2026Today5/28/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorReal Estate Industry REIT - Healthcare Facilities Sub-IndustryN/A Current SymbolLON:THRL CIKN/A Webwww.targethealthcarereit.co.uk Phone+44-131-6252951FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Price Target for Target Healthcare REITGBX 101 High Price TargetGBX 101 Low Price TargetGBX 101 Potential Upside/Downside-6.7%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)GBX 12.57 Trailing P/E Ratio8.61 Forward P/E Ratio17.39 P/E Growth1.48Net Income£72.07 million Net Margins104.45% Pretax MarginN/A Return on Equity10.73% Return on Assets3.86% Debt Debt-to-Equity Ratio27.14 Current RatioN/A Quick Ratio1.52 Sales & Book Value Annual Sales£83.69 million Price / Sales8.02 Cash FlowGBX 7.53 per share Price / Cash Flow14.37 Book ValueGBX 111.13 per share Price / Book0.97Miscellaneous Outstanding Shares620,237,000Free FloatN/AMarket Cap£671.10 million OptionableNot Optionable Beta0.69 Don't wait for the SpaceX IPOThe space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (LON:THRL) was last updated on 5/28/2026 by MarketBeat.com Staff. From Our PartnersWall Street’s $3.3B critical mineral darling just got spanked by a $300M junior …NevGold Corp. (OTCQX: NAUFF) just released drill results showing up to 53.71% antimony - potentially one of th...i2i Marketing Group, LLC | SponsoredSpaceX billions need somewhere to go — this is itThe SpaceX IPO is projected to raise $75 billion in a single day... When that happens, the insiders who cashed...Crypto 101 Media | SponsoredBNZI Breakout Watch: AI Growth Meets Turnaround Setup!Banzai International (NASDAQ: BNZI) reported full-year 2025 revenue of $12.2 million, up 169% year-over-year, ...Huge Alerts | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredThe math on the SpaceX IPO is brokenSpaceX is expected to go public at a $1.75 trillion valuation. For investors to see a 10x return, the company ...Weiss Ratings | SponsoredThey're not telling you how bad this could getValuations are stretched to levels seen only a handful of times in the last hundred years — yet most retiremen...Parkview Capital Group | SponsoredWhen SpaceX goes public your retirement pays the priceWhen SpaceX files its S-1, institutions will liquidate holdings, rebalance portfolios, and free up capital for...Reagan Gold Group | SponsoredOne page of the SpaceX S-1 will move this stock overnightWhen SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including powe...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Target Healthcare REIT Please log in to your account or sign up in order to add this asset to your watchlist. Share Target Healthcare REIT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
